What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant
Axovant Sciences has produced results from two separate studies related to neurodegenerative diseases, and its shares had a sharp gain to start off the week.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 106
Do E-Cigarettes Cause A Surge In Heart Attack Risk?
There has been little exact proof about how much damage e-cigarettes can do to health. Also know as “e-cigs,” “vapes,” “e-hookahs,” “vape pens” and “electronic nicotine delivery systems,” the public knows little about their…
Can Tonix Regain Its Former Glory With New Neurodegenerative Dysfunction Drug?
Tonix Pharma shares spiked on Friday after the firm announced that it received a patent from the European Patent Office for its “Method for Treating Neurodegenerative Dysfunction.”
Bio-Path Shares on the Warpath
Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm…
How Soon Will Robots Replace Doctors?
Artificial intelligence and robots are poised to play a bigger role in medicine and health care. Will robots replace doctors? When will that begin to happen? Do we know what to expect?
Why Bio-Path Shares Nearly Tripled
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double
Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall Street.
Why Ascendis Pharma Shares Hit an All-Time High
Ascendis Pharma shares spiked early Monday as the result of positive top-line results from its late-stage growth hormone study in children.
Are Nightstar Shareholders Getting Enough in the Buyout?
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Wedbush’s Top Biotech Picks Ahead of AACR Annual Meeting
Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has some ideas for what the big movers could be.
What Lexicon Pharma Could Mean for the Future of Diabetes
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista (sotagliflozin).
Is Immunogen Done After This Ovarian Cancer Study?
ImmunoGen shares were halved on Friday after the firm reported late-stage results from its ovarian cancer study.
Fast Food Much Less Healthy Than 3 Decades Ago
Fast food is usually characterized as unhealthy, with high amounts of fat, salt and sugar. A new study shows that this has worsened over the past 30 years.
What’s Next for Horizon Pharma After This Late-Stage TED Trial
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in most of the…